Waitlist and post-transplant outcomes in patients with NASH versus non-NASH hepatocellular carcinoma

被引:0
|
作者
Tan, D. [1 ]
Lim, W. H. [1 ]
Ng, C. H. [1 ]
Koh, B. [1 ]
Chan, K. E. [1 ]
Tan, C. [1 ]
Tang, A. [1 ]
Xiao, J. L. [1 ]
Zeng, R. [1 ]
Tay, P. [1 ]
Quek, J. [1 ]
Woo, F. [2 ]
Tseng, M. [3 ]
Syn, N. [1 ]
Teng, M. [1 ,2 ,4 ]
Tan, E. [1 ,2 ,4 ]
Huang, D. [1 ,2 ,4 ]
Siddiqui, M. S. [3 ]
Muthiah, M. [1 ,2 ,4 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Natl Univ Hlth Syst, Natl Univ Ctr Organ Transplantat, Singapore, Singapore
[3] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Richmond, VA 23284 USA
[4] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Dept Med, Singapore, Singapore
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
O-093
引用
收藏
页码:60 / 60
页数:1
相关论文
共 50 条
  • [41] Effects of Telmisartan on a Murine Model of Non-Alcoholic Steatohepatitis (NASH) and NASH-Related Hepatocellular Carcinoma
    Shibazaki, Yuichiro
    Fujii, Masato
    Wakamatsu, Kyoko
    Hashiguchi, Taishi
    Honma, Taihei
    Furuuchi, Miho
    Sakurai, Maki
    Nishimura, Nobuyo
    Yoneyama, Hiroyuki
    GASTROENTEROLOGY, 2012, 142 (05) : S543 - S543
  • [42] Worse Long-Term Post-Transplant Outcomes for Liver Recipients with Hepatocellular Carcinoma
    Luo, Xun
    Massie, Allan
    Choudhury, Rashikh
    Segev, Dorry
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 82 - 83
  • [43] Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates
    Thalji, L.
    Thalji, N.
    Ibrahim, S.
    Heimbach, J.
    Kamath, P.
    Haile, D.
    Kor, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1104 - 1104
  • [44] IMPACT OF BARIATRIC SURGERY ON LIVER TRANSPLANT OUTCOMES IN PATIENTS WITH NASH
    Kroner, Paul T.
    Kesler, Alex M.
    Thompson, Christopher C.
    GASTROENTEROLOGY, 2019, 156 (06) : S1247 - S1247
  • [45] Cardiophrenic lymph nodes in liver transplant candidates with hepatocellular carcinoma: imaging characteristics and post-transplant outcomes
    Lee, Christopher
    Kim, Andrew
    Santos, Idoia
    Cen, Yong
    Alexopoulos, Sophoclis
    Navarro, Shannon
    Wallman, Melissa
    Dhanireddy, Kiran
    Grant, Edward
    CLINICAL TRANSPLANTATION, 2014, 28 (12) : 1402 - 1409
  • [46] An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma
    Cheng, Jian-Wen
    Shi, Ying-Hong
    Fan, Jia
    Huang, Xiao-Wu
    Qiu, Shuang-Jian
    Xiao, Yong-Sheng
    Wang, Zheng
    Dai, Zhi
    Tang, Zhao-You
    Zhou, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1445 - 1453
  • [47] Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma
    Cheung, Siu Tim
    Fan, Sheung Tat
    Lee, Yuk Ting
    Chow, Jeremy P.
    Ng, Irene O.
    Fong, Daniel Y.
    Lo, Chung Mau
    TRANSPLANTATION, 2008, 85 (01) : 81 - 87
  • [48] GEOGRAPHICAL VARIATION IN WAITLIST AND POST-TRANSPLANT OUTCOMES AMONG PATIENTS LISTED FOR HEART TRANPLANTATION IN THE UNITED STATES
    Akintoye, Emmanuel
    Briasoulis, Alexandros
    Alvarez, Paulino
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1010 - 1010
  • [49] Sorafenib Use in High-Risk Post-Transplant Patients With Hepatocellular Carcinoma
    Padilla, Leybelis
    Russo, Mark
    Zamor, Philippe
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S329 - S330
  • [50] Comparison of Two Staging Systems for Hepatocellular Carcinoma in Post-Transplant Liver Patients
    Garcia-Buitrago, M.
    Bejarano, P.
    MODERN PATHOLOGY, 2011, 24 : 433A - 433A